---
title: HAS Healthcare Advanced Synthesis SA vs 重庆兴泰濠制药有限公司 (Sintaho)
slug_a: hashealthcare
slug_b: sintaho
site: cdmo
review_signal_gate: closed
canonical_path: /compare/hashealthcare/sintaho
generated_by: BioBM Editorial AI
---

# HAS Healthcare Advanced Synthesis SA vs 重庆兴泰濠制药有限公司 (Sintaho)

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

HAS Healthcare Advanced Synthesis SA (hashealthcare) is listed for cdmo. HAS Healthcare Advanced Synthesis is a Swiss CDMO producing cGMP APIs, HPAPIs and anticancer compounds from clinical to commercial use. Recent Swissmedic milestones include approval of its expanded Reduced Folates unit and inspection of its new ADC suite.

Services: 5. Modalities: 2. Indications: 1. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (5).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

重庆兴泰濠制药有限公司 (Sintaho) (sintaho) is listed for cdmo. China-based API and CDMO/CMO supplier focused on cytotoxic and OEB5 high-potency APIs, peptides, and XDC compounds. Reports FDA on-site inspections in 2024 and 2025 and product registrations in more than 30 countries.

Services: 4. Modalities: 2. Indications: 0. Locations: 1. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (4).

Review summary: Review summary withheld until site-level review gate opens.